Please see below the latest news related to the Optogenerapy project:
-
European Researchers Developed the first Biophotonic Implant to Deliver Therapeutic Proteins to Multiple Sclerosis Patients
in GeneralThe European Optogenerapy project has developed the first subcutaneous biophotonic implant using optogenetic technology to deliver doses of therapeutic proteins to......
-
Partners celebrate Optogenerapy’s project final meeting
in MeetingEurecat has hosted the 37-month meeting of Optogenerapy project in its facilities in Cerdanyola del Valles. On January 23-24, partners reviewed......
-
“Ultrasonic moulding is rapidly becoming a key enabling technology for the biomedical sector”
in InterviewIn this interview, Optogenerapy partner Joaquin Rodríguez Díaz-Caneja, Project Manager at Ultrasion, explains us what is Ultrasonic Moulding and how this......
-
Optogenerapy project pitched during MAX Advanced Manufacturing Congress
in EventCarlos Sáez, researcher at Eurecat’s Plastic Materials Unit, presented Optogenerapy project during the MAX – Advanced Manufacturing Congress. The congress took......
-
INSERM presents a poster at the 27th Annual Congress ESGCT
in EventOptogenerapy partner Emilie Audouard, postdoctoral researcher at the INSERM’s Institute of the Brain and Spine Diseases presented a poster based on......
-
Optogenerapy partners meet in Barcelona for their 34M Meeting
in MeetingOptogenerapy project partners gathered in Barcelona on Oct 21-22th to present the project’s latest results for the development of a bio-electronic implant......
-
Optogenerapy at the EU Workshop Performance Assessment and Standardisation in Biophotonics Workshop
in WorkshopMarc Folcher, Senior Scientist and Lecturer in bioengineering from the Department of Biosystems Science and Engineering at the Swiss Federal Institute......
-
Optogenerapy flexible electronics application in one of EuroNanoForum key sessions
in ConferenceOptogenerapy partner Eurecat attended the EuroNanoForum 2019 and delivered a presentation on how flexible electronics have been applied for the development of the......
-
“Standardisation in H2020 projects’ increases their impact and facilitates the exploitation of their results into the market”
in InterviewStandardisation is a voluntary agreement among the interested stakeholders, defining common provisions that facilitate their technical, commercial or managerial activities. Those......
-
SelectBio Conference exhibits poster on Optogenerapy’s bio-electronic cell-based implant
in ConferenceOptogenerapy project partner Eurecat has presented the poster “Bio-electronic cell-based implant for Multiple Sclerosis” during the SelectBIO Point-of-Care, Biosensors & Mobile Diagnostics Europe......
-
“Modelling leads to more stable and better optimized systems”
in InterviewOptogenerapy partner GeneXplain has built a mathematical model to further improve and optimize the optogenetic pathway of Optogenerapy’s medical device. The......
-
Literature Review on Multiple Sclerosis Patients’ Needs and Treatment Preferences
in General, PublicationResearchers from the Erasmus School of Health Policy & Management of the Erasmus University Rotterdam have done a systematic literature review using scientific......
-
Optics play a main role in efficiently delivering the light to the cells for Multiple Sclerosis drug generation
in InterviewIn Optogenerapy project, light fuels the medical device, the energy to activate the engineered cells in the chamber for the production......
-
OE-A Europe Meeting hosts presentation on Optogenerapy project
in EventOptogenerapy project has been presented during the Organic and Printed Electronics Association (OE-A) 44th Working Group Meeting, which has taken place......
-
Lodz University of Technology presents potential sterilization methods for Optogenerapy bio-electronic implant
in Event, PublicationOptogenerapy partner Lodz University of Technology has attended at the Annual Conference of Biomaterials in Medicine and Veterinary Medicine, which has......
-
Sterilisation methods applicable to Optogenerapy medical device divulged at ISBPPB 2018
in EventThe results of a review of sterilization methods to determine which ones are most suitable for Optogenerapy’s bio-electronic implant, have been......
-
NEOS Surgery Applies Innovation Management Methodology for Surgical Instrument Conceptualizing
in General, InnovationBy Mireia Dilmé – Exploitation, Innovation and Strategy Consultant at Eurecat Optogenerapy partner NEOS Surgery benefitted from the innovation management......
-
Innovation management in Optogenerapy: from training workshops to consultancy support
in GeneralBy Mireia Dilmé – Exploitation, Innovation and Strategy Consultant at Eurecat In today’s ever-changing market environment, managing innovation effectively has......
-
Paper on Optogenerapy published at Journal of Molecular Genetics and Medicine
in PublicationOptogenerapy partners published the paper “From Photobiolumination to Optogenerapy, Recent Advances in NIR Light Photomedicine Applications” at the Journal of Molecular......
-
“Optogenerapy’s printed electronics prove the potential of this technology for improving patient’s quality of life”
in InterviewWhenever we think of electronics, a PCB (Printed Circuit Board) full of conductive tracks and pads of laminated copper comes to......
-
“Microinjection by ultrasounds opens new opportunities for medical devices manufacturing”
in InterviewFrom the invention of the first man-made plastic in 1862, the plastic industry has grown exponentially in materials and techniques making......
-
Optogenerapy presented at workshop on the use of advanced materials for health applications
in EventBarcelona, 6th April, 2018 – Project partner Eurecat delivered a talk on Optogenerapy concept and expected impacts during the 1st Exploration......
-
Optogenerapy partner Eurecat presents poster at LOPEC 2018
in Event, PublicationMunich, 14th March, 2018 – Optogenerapy partner Mohammad Mashayekhi from Eurecat has presented the poster “Compact Low-resistance Screen-printed Flexible Antennas for......
-
Project partners celebrate Optogenerapy’s first year meeting at INSERM facilities
in MeetingParis, 23rd February, 2017 – Optogenerapy’s consortium has met in Paris at INSERM facilities for the project’s third meeting, marking one......
-
“A disruptive innovation for a novel non-invasive drug delivery”
in InterviewThe success of modern medicine results from a synergy between the development of drug delivery devices and the ever-growing drug industry.......
-
Optogenerapy poster exhibited at ESGCT Congress
in EventBerlin, 20th October, 2017 – The EU-funded Optogenerapy project was presented at the XXV Anniversary Congress of the European Society of......
-
Optogenerapy partners to meet in Basel for 2nd consortium meeting
in MeetingBarcelona, 11th September, 2017 – The Optogenerapy consortium will be gathered together for its second meeting after the project’s kick-off in......
-
Optogenerapy partner ETH publishes paper at Porto Biomedical Journal
in PublicationThe paper “Optogenerapy: When bio-electronic implant enters the modern syringe era”, breaking down the latest advances of the multidisciplinary technologies behind......
-
European consortium to create bio-electronic implants to treat Multiple Sclerosis
in GeneralBarcelona, 1st June, 2017 – Researchers from eleven institutions and companies in seven different European countries have started work within the......
-
Optogenerapy team starts working on bio-electronic implants to treat Multiple Sclerosis
in MeetingBarcelona 20th February, 2017 – Researchers from eleven institutions and companies in seven different European countries met at Eurecat’s facilities in......